181 related articles for article (PubMed ID: 22104131)
1. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
Peacock ZS; Jordan RC; Schmidt BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M
J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282
[TBL] [Abstract][Full Text] [Related]
3. Stromal myofibroblasts in central giant cell granuloma of the jaws cannot distinguish between non-aggressive and aggressive lesions.
Vered M; Nasrallah W; Buchner A; Dayan D
J Oral Pathol Med; 2007 Sep; 36(8):495-500. PubMed ID: 17686009
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of matrix metalloproteinase (MMP)-1 and -9 in central giant cell lesions of the jaws: implications for clinical behavior.
Tobón-Arroyave SI; Mideros-Simarra SM; Castaño-Ramírez LM; Flórez-Moreno GA; Isaza-Guzmán DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):755-63. PubMed ID: 20971661
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior.
Tobón-Arroyave SI; Hurtado-García P; García-Quintero OD; Isaza-Guzmán DM; Flórez-Moreno GA
J Oral Pathol Med; 2015 Oct; 44(9):752-60. PubMed ID: 25413222
[TBL] [Abstract][Full Text] [Related]
6. Do histologic criteria predict biologic behavior of giant cell lesions?
Peacock ZS; Resnick CM; Susarla SM; Faquin WC; Rosenberg AE; Nielsen GP; Schwab JH; Hornicek F; Ebb DH; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2012 Nov; 70(11):2573-80. PubMed ID: 22365980
[TBL] [Abstract][Full Text] [Related]
7. Giant cell granuloma of the jawbones--a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor.
Vered M; Buchner A; Dayan D
J Oral Pathol Med; 2006 Nov; 35(10):613-9. PubMed ID: 17032394
[TBL] [Abstract][Full Text] [Related]
8. CD34 staining density predicts giant cell tumor clinical behavior.
Susarla SM; August M; Dewsnup N; Faquin WC; Kaban LB; Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5):951-6. PubMed ID: 19375002
[TBL] [Abstract][Full Text] [Related]
9. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):994-1000. PubMed ID: 22365107
[TBL] [Abstract][Full Text] [Related]
11. Cellular cannibalism in central and peripheral giant cell granuloma of the oral cavity can predict biological behavior of the lesion.
Sarode SC; Sarode GS
J Oral Pathol Med; 2014 Jul; 43(6):459-63. PubMed ID: 24112367
[TBL] [Abstract][Full Text] [Related]
12. [Central giant cell lesions of the jaws: a clinicopathological study of 31 cases].
Liu B; Yu SF; Wu YT; Pang SZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):67-9. PubMed ID: 15774157
[TBL] [Abstract][Full Text] [Related]
13. [Coexpression of VEGF and bFGF is associated with increased vascular density in head and neck carcinomas].
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Laryngorhinootologie; 2000 Dec; 79(12):730-5. PubMed ID: 11199455
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws.
Sadri D; Hejazi M; Jahanbani J; Forouzandeh A
J Oral Pathol Med; 2010 May; 39(5):431-4. PubMed ID: 20202088
[TBL] [Abstract][Full Text] [Related]
15. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
16. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
[TBL] [Abstract][Full Text] [Related]
17. Central giant cell lesions of the jaws: a clinicopathologic study.
Chuong R; Kaban LB; Kozakewich H; Perez-Atayde A
J Oral Maxillofac Surg; 1986 Sep; 44(9):708-13. PubMed ID: 3462363
[TBL] [Abstract][Full Text] [Related]
18. Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics.
Resnick CM; Margolis J; Susarla SM; Schwab JH; Hornicek FJ; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2010 Jan; 68(1):130-7. PubMed ID: 20006167
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
